Related Experiment Videos
Interaction between biofilms formed by Staphylococcus epidermidis and quinolones
1Department of Medicine, Division of Infectious Diseases, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Diagnostic Microbiology and Infectious Disease
|August 15, 2001
Summary
Subinhibitory concentrations of fluoroquinolones like ciprofloxacin inhibit Staphylococcus epidermidis biofilm formation. Higher concentrations eradicate preformed biofilms on surfaces and catheters.
Area of Science:
- Microbiology
- Pharmacology
- Biomedical Engineering
Background:
- Staphylococcus epidermidis is a common cause of biofilm-related infections, particularly on medical devices.
- Fluoroquinolones are broad-spectrum antibiotics with potential anti-biofilm activity.
Purpose of the Study:
- To investigate the efficacy of pefloxacin, ciprofloxacin, norfloxacin, and ofloxacin against Staphylococcus epidermidis biofilms.
- To evaluate the impact of fluoroquinolones on bacterial adhesion and biofilm eradication.
Main Methods:
- Studied interaction of four fluoroquinolones with Staphylococcus epidermidis biofilms from clinical isolates.
- Assessed biofilm optical density and bacterial adhesion in vitro, including a vascular catheter model.
- Utilized scanning electron microscopy to visualize anti-biofilm activity.
Main Results:
- Subinhibitory concentrations (1/2-MIC and 1/8-MIC) reduced biofilm optical density significantly (22-74%).
- Higher concentrations (12.5-400 microg/mL) reduced preformed biofilm optical density by 45-77%.
- Fluoroquinolones inhibited bacterial adhesion to plastic and catheter surfaces, with higher concentrations eradicating established biofilms.
Conclusions:
- Subinhibitory fluoroquinolone concentrations effectively inhibit Staphylococcus epidermidis adhesion.
- Higher fluoroquinolone concentrations demonstrate potent eradication of preformed biofilms on vascular catheters.
- These findings suggest fluoroquinolones as potential agents for preventing and treating S. epidermidis biofilm infections.